Laurus Labs Forays Into Biotech Segment Via Acquisition

Laurus Labs forays into broader biologics & biotechnology segments by acquiring Richcore Lifesciences. Founder & CEO Satyanarayana Chava feels this acquisition will add 'fourth lever of growth' & fast-track its biotech ambitions.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.